NASDAQ:HRTX

Heron Therapeutics Stock Predictions

etoro logo Buy HRTX
*Your capital is at risk
$0.447
-0.0032 (-0.711%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

HRTX Prediction Chart

HRTX Predictions History

Latest community submissions for HRTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Aug 14, 2023 $1.66 +2.17% $1.51 X 90.39% 0
Aug 14, 2023 Bullish $1.51 X 0
Jul 25, 2023 $1.49 -3.19% $1.51 V 98.73% 2
Jul 25, 2023 $1.51 -1.99% $1.51 V 99.95% 10
Jul 25, 2023 Bullish $1.51 X 0
Apr 17, 2023 $2.63 -3.57% $2.87 X 91.72% 0
Apr 17, 2023 $2.67 -2.23% $2.87 X 93.00% 0
Apr 17, 2023 Bullish $2.87 V 1
Apr 11, 2023 $2.33 -3.65% $2.73 X 85.41% 0
Apr 11, 2023 $2.36 -2.28% $2.73 X 86.62% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for HRTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT HERON THERAPEUTICS
Heron Therapeutics
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acut...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE